Larimar will present three posters during the conference, one of which will also be presented as an oral presentation. The poster presentations are as follows: Effect of nomlabofusp administration on ...
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize drug ...
Data underscore the potential to leverage comprehensive epigenomic profiling from a simple blood test to explore central nervous system disease ...
Aston Institute for Membrane Excellence held its official academic launch event on 13 SeptemberMore than 100 biologists, chemists, physicists and engineers gathered at Aston University to learn about ...
Sparrow Pharmaceuticals today announced that it presented new data from its ongoing Phase 2 clinical trial of its HSD-1 inhibitor, clofutriben (referred to SPI-62 in the study), in combination with ...
Associates say a failed attempt to buy the Buffalo Bills in 2014 cleared a path for him to run for office and gave him a grudge against the league.
After a summer of excessive heat, massive flooding, raging wildfires and the earliest Category 5 hurricane ever recorded, communities and families are feeling the effects of the climate crisis ? and ...
The President made this commitment on Thursday during a meeting in Abuja with the global leadership of Coca-Cola, where the beverage ...
Reservations must be guaranteed with a credit card. The credit card expiration date must be March 2025, or later. The card provided will be charged a one (1) night’s room and current sales tax deposit ...
Discover how this versatile format can elevate your brand's narrative -- from showcasing sequential stories to highlighting ...
As my wife, Virginia, and I stroll through our magnificent City, we admire the beautiful paseos and the expansive open spaces ...
Title: GT-02287, a clinical stage GCase regulator, improves mitochondrial function and provides a neuroprotective effect in GBA1-Parkinson's disease models Presenting author: Natalia Perez-Carmona ...